Heart Failure Management
Classifying patients across heart failure stages
Heart failure is not a single event, it’s a progressive continuum that often begins silently and evolves over years.
While early detection is critical, ongoing management is what determines outcomes.
MyoStrain® enables clinicians to move from reactive to proactive guided therapy, providing quantitative insights to optimize care at every stage of disease progression.
February 5, 2023
Frontiers In Cardiovascular Medicine
Heart failure (HF) does not only reduce the life expectancy in patients, but their life is also often limited by HF symptoms leading to a reduced quality of life (QoL) and a diminished exercise capacity.
Heart failure (HF) does not only reduce the life expectancy in patients, but their life is also often limited by HF symptoms leading to a reduced quality of life (QoL) and a diminished exercise capacity. Novel parameters in cardiac imaging, including both global and regional myocardial strain imaging, promise to contribute to better patient characterization and ultimately to better patient management. However, many of these methods are not part of clinical routine yet, their associations with clinical parameters have been poorly studied. An imaging parameters that also indicate the clinical symptom burden of HF patients would make cardiac imaging more robust toward incomplete clinical information and support the clinical decision process.
January 25, 2023
Frontiers in Cardiovascular Medicine
This article demonstrates MyoStrain’s ability to identify patients with subclinical LV dysfunction and those at risk for heart failure-related outcomes compared with LVEF, providing an additional diagnostic window for prevention treatments.
January 5, 2023
Frotiners In Cardiovascular Medicine
The main management strategy of heart failure with preserved ejection fraction (HFpEF) is prevention since HFpEF is associated with many cardiovascular (CV) risk factors, especially since HFpEF is linked to a high risk for both mortality and recurrent heart failure (HF) hospitalizations. Therefore, there is a need for new tools to identify patients with a high risk profile early. Regional strain assessment by CMR seems to be superior in describing deformation impairment in HF. The MyoHealth score is a promising tool to identify cardiac changes early.
January 5, 2023
Hashemi, D. et al.
- This study found that the MyoHealth Score was able to detect differences in regional strain between healthy controls, asymptomatic patients with cardiovascular risk factors, and HFpEF patients — all of whom had similar and preserved LVEF — suggesting the tool can identify at-risk patients before symptoms develop.
March 1, 2022
Kazakauskaite, E. et al.
September 2023
Kazakauskaite, E. et al.
February 4, 2021
Hashemi, D. et al.